MyoKardia Inc (MYOK)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS
*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

1000 SIERRA POINT PARKWAY BRISBANE, CA 94005

MyoKardia, Inc. operates as a precision cardiovascular medicine company. The Company develops and commercializes targeted therapies for the treatment of serious and neglected rare cardiovascular diseases. MyoKardia conducts its business in the United States.

Data as of 2019-12-03 02:42:03 -0500
Market Cap3.013 Billion Shares Outstanding46.226 Million Avg 30-day Volume
P/E Ratio Dividend Yield EPS-5.217
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE Enterprise Value
Total Cash Current Debt Gross Profit
BETA 52-week High/Low66.44 / 39.01 Next Earnings Date Price to Cash FLow (P/CF)
Data provided by IEX Cloud
View SEC Filings from MYOK instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 18 -100.0% 0 (0.0%) 11 (0.68%) -100.0%
Funds Holding: 1 234 -99.57% (0.0%) 71 (4.42%)
13F shares: 55.46 Thousand 55.875 Million -99.9% 0 19.87 Million -100.0%
% Ownership 37.2627
New Positions: 43 7
Increased Positions 79 30
Closed Positions 226 42 438.1% 69 28 146.43%
Reduced Positions 77 21
Total Calls 0 135.13 Thousand -100.0% 0 66.2 Thousand -100.0%
Total Puts 0 114.147 Thousand -100.0% 0 13.8 Thousand -100.0%
PUT/CALL Ratio 0.84 0.21
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding MYOK (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding MYOK BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

BAUER JAKE CHIEF BUSINESS OFFICER

  • Officer
0 2020-11-17 1

PERRY MARK L

  • Director
0 2020-11-17 4

GIANAKAKOS ANASTASIOS PRESIDENT AND CEO

  • Officer
  • Director
0 2020-11-17 5

MCDOWELL ROBERT SCOTT CHIEF SCIENTIFIC OFFICER

  • Officer
0 2020-11-17 1

AGARWAL SUNIL

  • Director
0 2020-11-17 4

CRANSTON MARY B

  • Director
0 2020-11-17 6

YARNO WENDY L

  • Director
0 2020-11-17 4

POPOVITS KIMBERLY J

  • Director
0 2020-11-17 4

MEEKER DAVID P

  • Director
0 2020-11-17 4

HARRIS TAYLOR C. CHIEF FINANCIAL OFFICER

  • Officer
0 2020-11-17 1

FAIREY WILLIAM EVP, CHIEF COMMERCIAL OFFICER

  • Officer
0 2020-11-17 1

WAYNICK DENELLE J CHIEF LEGAL OFFICER

  • Officer
0 2020-11-17 3

LADD CYNTHIA J GENERAL COUNSEL

  • Officer
0 2020-02-14 0

LEE JUNE EVP, CHIEF DEVELOPMENT OFFICER

  • Officer
4,153 2019-09-23 0

SANOFI

  • 10% Owner
0 2019-02-13 0

LAMBING JOSEPH SEE REMARKS

  • Officer
0 2019-02-08 0

SEMIGRAN MARC CHIEF MEDICAL OFFICER

  • Officer
0 2019-02-08 0

MCDOWELL ROBERT SCOTT CHIEF SCIENTIFIC OFFICER

MCDOWELL ROBERT SCOTT CHIEF SCIENTIFIC OFFICER

  • Officer
1,158 2019-01-07 1

STARR KEVIN P

  • Director
  • 10% Owner
1,109,848 2018-03-07 0

THIRD ROCK VENTURES II, L.P.

THIRD ROCK VENTURES GP II, L.P.

TRV GP II, LLC

LEVIN MARK J

TEPPER ROBERT I

  • 10% Owner
No longer subject to file 2018-03-07 0

THIRD ROCK VENTURES III, L.P.

THIRD ROCK VENTURES GP III, L.P.

TRV GP III, LLC

LEVIN MARK J

TEPPER ROBERT I

  • 10% Owner
1,102,356 2018-01-03 0

LEVIN MARK J

  • 10% Owner
186,041 2017-12-31 0

TOPOL ERIC

  • Director
0 2017-06-14 0

CHAN STEVEN SEE REMARKS

  • Officer
0 2017-01-18 0

HOMCY CHARLES J

  • Director
6,496 2016-11-29 0

FOX JONATHAN C CHIEF MEDICAL OFFICER

  • Officer
240,997 2016-04-29 0

THIRD ROCK VENTURES II, L.P.

THIRD ROCK VENTURES GP II, L.P.

TRV GP II, LLC

THIRD ROCK VENTURES III, L.P.

THIRD ROCK VENTURES GP III, L.P.

TRV GP III, LLC

LEVIN MARK J

TEPPER ROBERT I

  • 10% Owner
1,496,598 2015-11-03 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
American Century Quantitative Equity Funds, Inc.- AC Alternatives Equity Market Neutral Fund MYOK -1573.0 shares, $-114648.11 2019-12-31 N-PORT
American Century Quantitative Equity Funds, Inc.- AC Alternatives Disciplined Long Short Fund MYOK -1004.0 shares, $-73176.54 2019-12-31 N-PORT
American Century Quantitative Equity Funds, Inc.- Core Equity Plus Fund MYOK -7689.0 shares, $-400981.35 2019-09-30 N-PORT
American Century Quantitative Equity Funds, Inc.- NT Core Equity Plus Fund MYOK -24995.0 shares, $-1303489.25 2019-09-30 N-PORT
Trust for Professional Managers- Convergence Market Neutral Fund MYOK -665.0 shares, $-72777.6 2020-08-31 N-PORT
FundVantage Trust- Gotham Enhanced Index Plus Fund MYOK -3.0 shares, $-140.64 2020-03-31 N-PORT
FundVantage Trust- Gotham Index Plus All-Cap Fund MYOK -33.0 shares, $-1547.04 2020-03-31 N-PORT

Elevate your investments